HomeInsightsPE

Wockhardt Ltd PE Ratio

Wockhardt Ltd PE Ratio

stocks purchased

₹ 3.1 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

22.1 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Wockhardt Ltd

NSE: WOCKPHARMA

PE

-

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Wockhardt Ltd is 0 as of 12 Dec 15:30 PM .
  • The P/E Ratio of Wockhardt Ltd changed from 6.6 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Latest Trading Price of Wockhardt Ltd is ₹ 1389 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Wockhardt Ltd

No data available

Company Fundamentals for Wockhardt Ltd

No data available

Image

Wockhardt Ltd

NSE: WOCKPHARMA

Share Price

₹ 1389.25

-36.40 (-2.55%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Wockhardt Ltd

1M

1Y

3Y

5Y

Monitoring Wockhardt Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20241389.25
11 Dec 20241425.65
10 Dec 20241398.8
09 Dec 20241395.75
06 Dec 20241389.85
05 Dec 20241434
04 Dec 20241437.35
03 Dec 20241403.7
02 Dec 20241429
29 Nov 20241408.4

SWOT Analysis Of Wockhardt Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Wockhardt Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Wockhardt Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Wockhardt Ltd022,571
Sun Pharmaceuticals Industries Ltd384,32,948
Divis Laboratories Ltd861,57,873
Cipla Ltd251,16,809
Torrent Pharmaceuticals Ltd641,12,638
Mankind Pharma Ltd501,06,198

Key Valuation Metric of Wockhardt Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Wockhardt Ltd

No data available

* All values are in crore

Historical Revenue of Wockhardt Ltd

No data available

* All values are in crore

Historical EBITDA of Wockhardt Ltd

No data available

* All values are in crore

Historical Net Profit of Wockhardt Ltd

No data available

* All values are in crore

Historical Dividend Payout of Wockhardt Ltd

No data available

* All values are in %

About Wockhardt Ltd

  • Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world.
  • The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
  • It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out. The Company has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland.
  • It has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses.
  • Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'.

Wockhardt Ltd News Hub

News

Wockhardt reports consolidated net loss of Rs 14.00 crore in the June 2024 quarter

Net Loss of Wockhardt reported to Rs 14.00 crore in the quarter ended June 2024 as against...

Read more

2024-08-09 00:00:00

News

Wockhardt to table results

Wockhardt will hold a meeting of the Board of Directors of the Company on 9 August 2024. P...

Read more

2024-08-08 00:00:00

News

Wockhardt allots 8,610 equity shares under ESOS

Wockhardt has allotted 8,610 equity shares under ESOS in 26 August 2024. With this allotme...

Read more

2024-08-26 00:00:00

News

Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections

In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has su...

Read more

2024-09-19 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Wockhardt Ltd

What is the current PE Ratio of Wockhardt Ltd?

The Current PE Ratio of Wockhardt Ltd is 0.0 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Wockhardt Ltd last year?

The PE Ratio of Wockhardt Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Wockhardt Ltd indicate about its stock?

The PE Ratio of Wockhardt Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Wockhardt Ltd.

What is the PE Ratio Growth of Wockhardt Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Wockhardt Ltd grew by -% whereas, the EPS ratio grew by 54.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions